# Dauntless Biotherapeutics

Source: https://onco.cc/companies/dauntless-biotherapeutics/  
OnCo record `dauntless-biotherapeutics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Dauntless Biotherapeutics is a San Diego area company developing an antibody that carries a drug to cancer cells, aimed at cancers with few treatment options.

## Summary

Dauntless Biotherapeutics, Inc. is a private preclinical oncology company developing an antibody-drug conjugate against an undisclosed tumour-associated antigen; its website says it is raising a seed round for lead optimisation, in vivo and non-GLP toxicity studies before an investigational new drug filing. In fiscal year 2026 the National Cancer Institute funded its SBIR project on a dual-function antibody therapeutic to overcome breast cancer resistance (1R43CA306683-01A1, USD 400,000).

## Fields

- Kind: Company
- Last checked: 2026-11-04
- Also known as: DAUNTLESS BIOTHERAPEUTICS, INC.
- HQ: San Diego, CA
- Type: biotech
- Website: https://www.dauntlessbiotherapeutics.com/

## Notes

- NIH RePORTER gives San Diego; the website gives an address in Carlsbad, California. Read on 4 November 2026. The site names no product.

## Sources

- Official website: https://www.dauntlessbiotherapeutics.com/
- NIH RePORTER: 1R43CA306683-01A1: https://reporter.nih.gov/project-details/11407449

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- fronts: [Antibody-Drug Conjugates](https://onco.cc/fronts/adcs/)
- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)

---
JSON: https://onco.cc/api/v1/entities/dauntless-biotherapeutics.json